IVIVA Medical Company
IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state renal disease (ESRD). At IVIVA we’re developing therapies using proprietary printed biologic scaffolds to replicate physiologically functional tissue constructs; platforms with the potential to replicate autologous renal function. Our composite hydrogel scaffolds are created using computer designed architecture and provide a unique starting point for developing many types of perfusable tissue constructs. Along with our tissue engineering platforms we have developed a variety of biomimetic systems capable of modeling whole organ function in a range of tissue types
Industry:
BioEngineering
Headquarters:
Beverly, Massachusetts, United States
Founded Date:
2013
Employees Number:
11-50
Investors Number:
2
Total Funding:
n/a
Estimated Revenue:
Less than $1M
Last Funding Date:
2021
Last Funding Type:
Seed
Register and Claim Ownership